» Articles » PMID: 27568083

Imaging Human Melanoma Using a Novel Tc-99m-labeled Lactam Bridge-cyclized Alpha-MSH Peptide

Overview
Specialty Biochemistry
Date 2016 Aug 29
PMID 27568083
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, the human melanoma targeting property of (99m)Tc(EDDA)-HYNIC-AocNle-CycMSHhex {hydrazinonicotinamide-8-aminooctanoic acid-Nle-c[Asp-His-DPhe-Arg-Trp-Lys]-CONH2} was determined in M21 human melanoma-xenografts to demonstrate its potential for human melanoma imaging. The IC50 value of HYNIC-AocNle-CycMSHhex was 0.48±0.01nM in M21 human melanoma cells (1281receptors/cell). The M21 human melanoma uptake of (99m)Tc(EDDA)-HYNIC-AocNle-CycMSHhex was 4.03±1.25, 3.26±1.23 and 3.36±1.48%ID/g at 0.5, 2 and 4h post-injection, respectively. Approximately 92% of injected dose cleared out the body via urinary system at 2h post-injection. (99m)Tc(EDDA)-HYNIC-AocNle-CycMSHhex showed high tumor/blood, tumor/muscle and tumor/skin uptake ratios after 2h post-injection. The M21 human melanoma-xenografted tumor lesions were clearly visualized by SPECT/CT using (99m)Tc(EDDA)-HYNIC-AocNle-CycMSHhex as an imaging probe at 2h post-injection. Overall, (99m)Tc(EDDA)-HYNIC-AocNle-CycMSHhex exhibited favorable human melanoma imaging property, highlighting its potential as an imaging probe for human metastatic melanoma detection.

Citing Articles

Advances in Development of Radiometal Labeled Amino Acid-Based Compounds for Cancer Imaging and Diagnostics.

Mikulova M, Mikus P Pharmaceuticals (Basel). 2021; 14(2).

PMID: 33669938 PMC: 7924883. DOI: 10.3390/ph14020167.


F-Labeled Cyclized α-Melanocyte-Stimulating Hormone Derivatives for Imaging Human Melanoma Xenograft with Positron Emission Tomography.

Zhang C, Zhang Z, Merkens H, Zeisler J, Colpo N, Hundal-Jabal N Sci Rep. 2019; 9(1):13575.

PMID: 31537869 PMC: 6753210. DOI: 10.1038/s41598-019-50014-5.


Evaluation of a Novel Pb-203-Labeled Lactam-Cyclized Alpha-Melanocyte-Stimulating Hormone Peptide for Melanoma Targeting.

Yang J, Xu J, Cheuy L, Gonzalez R, Fisher D, Miao Y Mol Pharm. 2019; 16(4):1694-1702.

PMID: 30763112 PMC: 6443429. DOI: 10.1021/acs.molpharmaceut.9b00025.


Ga-DOTA-GGNle-CycMSH targets the melanocortin-1 receptor for melanoma imaging.

Yang J, Xu J, Gonzalez R, Lindner T, Kratochwil C, Miao Y Sci Transl Med. 2018; 10(466).

PMID: 30404861 PMC: 6383514. DOI: 10.1126/scitranslmed.aau4445.


The Value of Technetium-99m Labeled Alpha-Melanocyte-Stimulating Hormone (Tc-α-MSH) in Diagnosis of Primary and Metastatic Lesions of Malignant Melanoma.

Farzanefar S, Etemadi R, Shirkhoda M, Mahmoodzadeh H, Erfani M, Fallahi B Asia Ocean J Nucl Med Biol. 2018; 6(2):155-160.

PMID: 29998149 PMC: 6038966. DOI: 10.22038/aojnmb.2018.30101.1204.


References
1.
Siegrist W, Solca F, Stutz S, GIUFFRE L, Carrel S, Girard J . Characterization of receptors for alpha-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 1989; 49(22):6352-8. View

2.
Raposinho P, Correia J, Alves S, Botelho M, Santos A, Santos I . A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting. Nucl Med Biol. 2007; 35(1):91-9. DOI: 10.1016/j.nucmedbio.2007.08.001. View

3.
Miao Y, Whitener D, Feng W, Owen N, Chen J, Quinn T . Evaluation of the human melanoma targeting properties of radiolabeled alpha-melanocyte stimulating hormone peptide analogues. Bioconjug Chem. 2003; 14(6):1177-84. DOI: 10.1021/bc034069i. View

4.
Tatro J, Reichlin S . Specific receptors for alpha-melanocyte-stimulating hormone are widely distributed in tissues of rodents. Endocrinology. 1987; 121(5):1900-7. DOI: 10.1210/endo-121-5-1900. View

5.
Chen J, Cheng Z, Hoffman T, Jurisson S, Quinn T . Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues. Cancer Res. 2000; 60(20):5649-58. View